NCT07558564 Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies
| NCT ID | NCT07558564 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ReSport Clinic |
| Condition | Patellar Tendinopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2026-04 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2026-04 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.
Eligibility Criteria
Inclusion Criteria: * Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration \>6 weeks) * Age \>18 years * Provision of written informed consent * Willingness and ability to complete follow-up assessments for 12 months Exclusion Criteria: * Surgical treatment of the affected tendon within the previous 6 months * Corticosteroid injection within the last month * Systemic inflammatory disease (e.g., rheumatoid arthritis) * Coagulopathies or ongoing anticoagulant therapy * Complete blood count showing a platelet concentration \<100 × 10⁹/L (to exclude patients with potential thrombocytopenia) * Pregnancy or breastfeeding
Contact & Investigator
Ferran Abat Gonzalez, MD PhD
PRINCIPAL INVESTIGATOR
ReSport Clinic
Frequently Asked Questions
Who can join the NCT07558564 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Patellar Tendinopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07558564 currently recruiting?
Yes, NCT07558564 is actively recruiting participants. Contact the research team at abat@resportclinic.com for enrollment information.
Where is the NCT07558564 trial being conducted?
This trial is being conducted at A Coruña, Spain, Barcelona, Spain, Barcelona, Spain, Madrid, Spain and 1 additional location.
Who is sponsoring the NCT07558564 clinical trial?
NCT07558564 is sponsored by ReSport Clinic. The principal investigator is Ferran Abat Gonzalez, MD PhD at ReSport Clinic. The trial plans to enroll 2,000 participants.